Evidence map›Paper›PMID 37723062›Full record

ReviewZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2023

[MDT management of nonalcoholic fatty liver disease].

C H Yu

Abstract readReviewEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Review in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. [Analysis of non-alcoholic fatty liver disease differences from metabolic dysfunction-associated fatty liver disease based on clinical features].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

C H YuDepartment of Gastroenterology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the clinic and is closely associated with obesity and related metabolic diseases such as type 2 diabetes, cardiovascular and cerebrovascular diseases, and chronic renal disease. The clinical harm is becoming increasingly severe. Multidisciplinary diagnosis and treatment (MDT) management is an effective way to improve the efficiency of NAFLD prevention and treatment, but the specific implementation path remains to be explored. This article reviews the theoretical basis, implementation path, dilemmas, and challenges of MDT management for NAFLD patients in order to provide a reference for better NAFLD prevention and treatment.

Indexed as

Diabetes Mellitus, Type 2Kidney Failure, ChronicNon-alcoholic Fatty Liver DiseaseRenal Insufficiency, ChronicHumansObesityDiagnosisMetabolic dysfunction-associated steatotic liver diseaseMultidisciplinary teamNonalcoholic fatty liver diseaseTreatment

Identifiers

PMID37723062
PMCPMC12814411

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.